ArticleRSC advances2026
Valorization of ductile cast iron solid waste as a high-performance adsorbent for crystal violet removal: characterization, optimization, and mechanistic insights.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Industrial textile wastewater containing synthetic dyes cause serious environmental and health risk, whereas ductile cast iron (DCI) foundries generate over 500 000 tons of waste annually. This study utilizes DCI solid waste as an adsorbent to remove the crystal violet (CV) dye from wastewater. Techniques (XRF, XRD, BET, SEM-EDX, FTIR, TGA-DTG, zeta potential) proved that the waste contains 88.0 wt% periclase (MgO) with nanoscale, high surface area, and abundant surface hydroxyl groups. Response surface methodology showed that the most significant parameters were the adsorbent dose and time contact. The optimal conditions give 93.7% removal efficiency at initial concentration: 38.7 mg L
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.